Publicacions en què col·labora amb Lucas Taoro González (19)

2016

  1. Extracellular cGMP Modulates Learning Biphasically by Modulating Glycine Receptors, CaMKII and Glutamate-Nitric Oxide-cGMP Pathway

    Scientific Reports, Vol. 6

  2. Hyperammonemia alters glycinergic neurotransmission and modulation of the glutamate-nitric oxide-cGMP pathway by extracellular glycine in cerebellum in vivo

    Journal of Neurochemistry, Vol. 137, Núm. 4, pp. 539-548

  3. Hyperammonemia induces glial activation, neuroinflammation and alters neurotransmitter receptors in hippocampus, impairing spatial learning: Reversal by sulforaphane

    Journal of Neuroinflammation, Vol. 13, Núm. 1

  4. In vivo administration of extracellular cGMP normalizes TNF-α and membrane expression of AMPA receptors in hippocampus and spatial reference memory but not IL-1β, NMDA receptors in membrane and working memory in hyperammonemic rats

    Brain, Behavior, and Immunity, Vol. 57, pp. 360-370

  5. Infliximab reduces peripheral inflammation, neuroinflammation, and extracellular GABA in the cerebellum and improves learning and motor coordination in rats with hepatic encephalopathy

    Journal of Neuroinflammation, Vol. 13, Núm. 1

  6. Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia

    Journal of Neuroinflammation, Vol. 13, Núm. 1

  7. Reducing peripheral inflammation with infliximab reduces neuroinflammation and improves cognition in rats with hepatic encephalopathy

    Frontiers in Molecular Neuroscience, Vol. 9, Núm. NOV2016